1EL0 | Immune System | date | Mar 11, 2000 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
title | Solution Structure Of The Human Cc Chemokine, I-309 | ||||||||||
authors | D.W.Keizer, M.P.Crump, T.W.Lee, C.M.Slupsky, I.Clark-Lewis, B.D.S | ||||||||||
compound | source | ||||||||||
Molecule: I-309 Chain: A Engineered: Yes |
Synthetic: Yes Other_details: This Sequence Occurs Naturally In Humans | ||||||||||
method | Solution NMR | ||||||||||
Gene Ontology |
| ||||||||||
Primary reference | Human CC chemokine I-309, structural consequences of the additional disulfide bond., Keizer DW, Crump MP, Lee TW, Slupsky CM, Clark-Lewis I, Sykes BD, Biochemistry 2000 May 23;39(20):6053-9. PMID:10821677 |
Data retrieval |
View 1EL0 in 3D |
Visual 3D analysis of 1EL0 |
Structure-derived information |
- Domain d1el0a_, region A [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1EL0 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |